The new anthraquinone derivative, 6,8-di-O-methylaverantin (1), together with six known congeners (2-7), were characterized from a culture extract of the marine algous fungus, Aspergillus versicolor EN-7. Their structures were elucidated by spectroscopic methods. A bioassay showed compounds 1, 2 and 5 to have weak inhibition against Escherichia coli, while compound 5 also displayed weak inhibition against Staphylococcus aureus.
Marine-derived fungi have been reported to possess high biodiversity with the potential to produce prolific bioactive substances. [1] [2] [3] Our successive investigations on new bioactive metabolites of marine algous endophytic fungi [4] [5] [6] [7] [8] [9] enabled us to isolate a pure strain from the inner tissue of the brown alga, Sargassum thunbergii, that had been collected along the Qingdao coastline of Shandong Province, China, by using a previously reported protocol. 4) The fungus was identified as Aspergillus versicolor EN-7 by a sequence analysis of the ITS1-5.8S-ITS2 rDNA's PCR product, using the previously described procedure. 4) The sequence data obtained from the fungal strain have been deposited at GenBank with accession no. EU042148, showed 99% similarity to those of A. versicolor (compared to EF125026 in GenBank). A chemical investigation of A. versicolor EN-7 resulted in the isolation and identification of one new (6,8-di-O-methylaverantin, 1) and six known (2-7) anthraquinone derivatives (Fig. 1) . This paper describes the isolation, structural elucidation, and antimicrobial evaluation of compounds 1-7.
The fermentation was carried out in 1-L Erlenmeyer flasks containing 300 mL of a culture medium composed of 2% glucose (w/v), 0.5% peptone (w/v, Beijing Aoboxing Bio-tech Co.), 0.3% yeast extract (w/v, Guangdong Yipingxian Biotechnology Co.), 20% potato extract (v/v, equivalent to 80 g of potato), and 50% filtered sea water (v/v). The pH value was adjusted to 6.8 before autoclaving, and static fermentation was carried out at 25 C for 30 d. The resulting culture broth (30 L) was filtered through absorbent cotton to separate the mycelia and supernatant. The mycelia were airdried, disrupted, and extracted with MeOH, while the supernatant was concentrated in vacuo and then extracted with EtOAc. The two extracts were combined and evaporated under reduced pressure to yield a crude extract (35.0 g) which was subjected to CC (SiO 2 , 200-300 mesh) by eluting stepwise with petroleum ether (PE)-EtOAc and CHCl 3 -MeOH to give 10 fractions (Fr. I-X). Fr. III (1.6 g) was subsequently subjected to repeated CC (SiO 2 , CHCl 3 /acetone 40:1 and PE/EtOAc 2.5:1) to provide compound 3 (28.0 mg). Fr. IV (2. Detailed interpretation of the MS and NMR data and by comparing with the data in literature reports enabled the structures of the known compounds to be determined as 6,8-di-O-methylversiconol (2), 10) 2 carbon signals, with two of them being carbonyl carbons at C 185.9 (s, C-9) and 181.7 (s, C-10).
The structure of compound 1 was elucidated and supported by all spectral data as well as by 1 H-1 H COSY and HMBC correlations as described later. A detailed comparison of the 1 H-and 13 C-NMR data (Table 1 ) of 1 with those of 2, an anthraquinonoid metabolite identified from mangrove-derived endophytic fungal strain ZSUH-36, 10) revealed that these two compounds had the same anthraquinone nucleus. However, the side chain substitution at C-2 of 1 was determined to be 1-hydroxyhexyl, this being different from that of 2. This was evident by the presentation of the corresponding signals, including one oxymethine [ 0 through H-6 0 supported the presence of a 1-hydroxyhexyl moiety (Fig. 2) , and the placement of this substitution at C-2 of the anthraquinone nucleus was confirmed by the HMBC correlations from H-1 0 ( H 5.14) to C-2 ( C 122.6) and C-3 ( C 162.0). The structure of compound 1 was therefore identified as 1,3-dihydroxy-2-(1-hydroxyhexyl)-6,8-dimethoxyanthracene-9,10-dione, this being the 6,8-di-O-methyl derivative of averantin.
14) Compound 1 was therefore named 6,8-di-O-methylaverantin. The absolute configuration at C-1 0 of 1 was determined to be S by a comparison of its optical rotation (½ D 20 À92:2, c ¼ 0:29, EtOH) with that of (À)-averantin (½ D 22 À138, c ¼ 0:37, EtOH). 15) All of the isolated compounds were tested for their antimicrobial activity against Escherichia coli, Staphylococcus aureus, Candida albicans and Aspergillus niger by the disk diffusion method.
16) Compounds 1, 2 and 5 showed weak antibacterial activity against E. coli, with the inhibition zones (È) 7.0, 6.5, and 6.5 mm, respectively, at 20 mg/disk, while compound 5 also showed weak antibacterial activity against S. aureus with the inhibition zones (È) 7.0 mm at 20 mg/disk. None of these compounds showed any marked antifungal activity against C. albicans and A. niger. Chloramphenicol was used as positive control in the antibacterial test against E. coli and S. aureus (È ¼ 22 and 25 mm, respectively, at 20 mg/disk), while amphotericin B was used as positive control in the antifungal assay against C. albicans and A. niger (È ¼ 12 and 16 mm, respectively, at 20 mg/disk). 
